Market Value113,198,000
Total Holdings52
File Date2017-08-10
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARAV / Aravive, Inc.
/ Achaogen Inc
ALNY / Alnylam Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
KMI / Kinder Morgan, Inc.
WVE / Wave Life Sciences Ltd.
FOLD / Amicus Therapeutics, Inc.
LJPC / La Jolla Pharmaceutical Co.
LOXO / Loxo Oncology, Inc.
AWI / Armstrong World Industries, Inc.
ESPR / Esperion Therapeutics, Inc.
COMM / CommScope Holding Company, Inc.
SRPT / Sarepta Therapeutics, Inc.
WBC / Wabco Holdings, Inc.
LPLA / LPL Financial Holdings Inc.
NXTM / NxStage Medical, Inc.
LSXMK / Liberty Media Corp. (New Liberty SiriusXM) Series C
GBT / Global Blood Therapeutics Inc.
FOXA / Fox Corporation
BHI / Baker Hughes Inc.
XNCR / Xencor, Inc.
BIVV / Bioverativ Inc.
NLTX / Neoleukin Therapeutics, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
LEXEB / Liberty Expedia Holdings, Inc. Series B
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
VSAT / Viasat, Inc.
TRN / Trinity Industries, Inc.
MYOV / Myovant Sciences Ltd
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
SGEN / Seagen Inc
INCY / Incyte Corporation
WTW / Willis Towers Watson Public Limited Company
ACGL / Arch Capital Group Ltd.
GHDX / Genomic Health, Inc.
RARX / Ra Pharmaceuticals, Inc.
MSFT / Microsoft Corporation
AXTA / Axalta Coating Systems Ltd.
ADS / Bread Financial Holdings Inc
STX / Seagate Technology Holdings plc
TVTX / Travere Therapeutics, Inc.
BRK.A / Berkshire Hathaway Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
MS / Morgan Stanley
CBRE / CBRE Group, Inc.
ESRX / Express Scripts Holding Co.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
QRTEA / Qurate Retail Inc - Series A
ZGNX / Zogenix Inc
SMLP / Summit Midstream Partners, LP - Limited Partnership
AVXS / AveXis, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
ARDX / Ardelyx, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
NBIX / Neurocrine Biosciences, Inc.